- DSpace Startseite
- →
- Neurología
- →
- Movimientos Anormales
- →
- Recent submissions
- Políticas del Repositorio
- Contacto y sugerencias
JavaScript is disabled for your browser. Some features of this site may not work without it.
Movimientos Anormales: Recent submissions
Anzeige der Dokumente 1-20 von 67
-
(IOS Press, 2024-03-14)The movement toward prevention trials in people at-risk for Parkinson's disease (PD) is rapidly becoming a reality. The authors of this article include a genetically at-risk advocate with the LRRK2 G2019 S variant and two ...
-
(2016)Introducción: Las ataxias espinocerebelosas (SCA) son un grupo de trastornos neurodegenerativos y heterogéneos desde el punto de vista clínico y genético que se caracterizan por la presencia de ataxia progresiva como ...
-
(Wiley, 2024-02-28)Background: One of the characteristics of parkinsonian tremor is that its amplitude decreases with movement. Current models suggest an interaction between basal ganglia (BG) and cerebello-thalamo-cortical circuits in ...
-
(Public Library of Science, 2023-10-03)Parkinson's disease (PD) is the fastest-growing neurodegenerative disorder, currently affecting ~7 million people worldwide. PD is clinically and genetically heterogeneous, with at least 10% of all cases explained by a ...
-
(Wiley, 2023-09-06)Background: Postural abnormalities involving the trunk are referred to as axial postural abnormalities and can be observed in over 20% of patients with Parkinson's disease (PD) and in atypical parkinsonism. These symptoms ...
-
(Wiley, 2023-07-13)Resumen no disponible
-
(Wiley, 2023-12-26)
-
Clinical correlates of fear of falling in progressive supranuclear palsy and multiple system atrophy (Wiley, 2023-05-14)Background and purpose: Clinical correlates of fear of falling (FoF) are scarcely studied in patients with progressive supranuclear palsy (PSP) and multiple system atrophy (MSA). This study was undertaken to evaluate the ...
-
(Wiley, 2023-06-13)Background: There is growing clinical and research utilization of genetic testing in Parkinson's disease (PD), including direct-to-consumer testing. Objectives: The aim is to determine the international landscape of ...
-
(Wiley, 2023-06-27)Genetic testing for persons with Parkinson's disease is becoming increasingly common. Significant gains have been made regarding genetic testing methods, and testing is becoming more readily available in clinical, research, ...
-
Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson's Disease: A Systematic Review (Wiley, 2023-06-14)Background: Continuous subcutaneous apomorphine infusion (CSAI) is one of the advanced therapies for Parkinson's disease (PD). Methods: A systematic review of all published articles in English on CSAI for PD till January ...
-
(Wiley, 2023-02-21)Resumen no disponible.
-
(Steinkopff, 2023-03-27)Purpose: Despite the availability of the Unified Multiple System Atrophy (MSA) Rating Scale (UMSARS) for almost two decades, studies still use scales developed for Parkinson's disease (PD) or ataxia (ATX). Our aim was to ...
-
(Wiley, 2022-12-09)
-
(Wiley, 2023-01-24)Background: As gene-targeted therapies are increasingly being developed for Parkinson's disease (PD), identifying and characterizing carriers of specific genetic pathogenic variants is imperative. Only a small fraction of ...
-
(Elsevier, 2023-01-11)Background: Whether there may be any relationship between stressful or traumatic life events (LE) and the subsequent motor symptoms onset in Parkinson's disease (PD) is still controversial. Objectives: To explore whether ...
Anzeige der Dokumente 1-20 von 67
Atribución 4.0 Internacional (CC BY 4.0)